Brief: Diamyd Medical AB - Completes Interim Efficacy Analysis In Phase 3 Diagnode-3 Trial
27/03/2026 19:22
March 27 (Reuters) - Diamyd Medical AB DMYDb.ST: DIAMYD MEDICAL AB - COMPLETES INTERIM EFFICACY ANALYSIS IN PHASE 3 DIAGNODE-3 TRIAL DIAMYD MEDICAL AB - INTERIM ANALYSIS DID NOT SHOW STATISTICAL SIGNIFICANCE ON PRIMARY ENDPOINT DIAMYD MEDICAL AB - PRE-SPECIFIED CRITERIA TO CONTINUE TRIAL NOT MET DIAMYD MEDICAL AB - NO SAFETY CONCERNS IDENTIFIED DURING INTERIM REVIEW DIAMYD MEDICAL AB - TO PROVIDE UPDATE NO LATER THAN MARCH 29, 2026 Source text: ID:nWkrb5P5h0 Further company coverage: [DMYDb.ST] ((Reuters.Briefs@thomsonreuters.com;))